Early Referrals for Transplantation May Improve Overall Survival in Older Patients with Myelodysplastic Syndrome
AML Content Hub
Corey Cutler, MD, MPH, medical director of the Adult Stem Cell Transplantation Center at Dana-Farber Cancer Institute, discusses Blood and Marrow Clinical Trials Network Study 1102, comparing patients aged 50–75 with advanced myelodysplastic syndrome who were matched with a stem cell transplant donor and those who did not receive transplant. After three years, individuals with donors achieved around 50% survival, while those with no donor had approximately 30% survival. Dr. Cutler hopes to see more patients referred early on for transplantation to enhance chances of receiving stem cell transplants.
